Lucideon Appoints Pharmaceutical Quality Manager
Lucideon has appointed Mick Tait as Pharmaceutical Quality Manager. Mick will be responsible for maintaining compliance of the Pharmaceutical Chemistry and Pharmaceutical Microbiology divisions to EU Good Manufacturing Practice (GMP) Guidelines.
In a career spanning 5 decades, Mick has gained substantial experience in a variety of Quality, Technical Support and Production related roles within the pharmaceutical industry. Prior to joining Lucideon, Mick was responsible for quality and technical support in the manufacture of pharmaceutical products. Mick was an IRCA qualified Pharmaceutical Lead Supplier Auditor, performing regular supplier quality audits, internal audits/self-inspections and he regularly participated in MHRA and FDA regulatory inspections.
“I am delighted to have joined Lucideon at a time of growth and continuous improvement. There is a lot of energy within the Pharma team and I am looking forward to making a significant contribution here.
"Having been on the ‘other side of the fence’ (manufacturing) for significant periods of my career, I have a good understanding of the QC testing needs of pharmaceutical manufacturers and associated regulatory requirements. I will be bringing that knowledge to support the expertise already present here at Lucideon and hence continue to grow our offering to the pharmaceutical sector.”
Lucideon Healthcare partners with clients across the globe to support their materials challenges throughout the lifecycle of their products. Through expert consultancy, technology development, and testing and characterization services, Lucideon Healthcare works as an extension to its clients’ teams, providing quicker routes to market, competitive advantage, regulatory approvals, and game-changing materials science. With technical expertise, industry experience, and analytical and materials know-how, Lucideon Healthcare works across a range of segments, including orthopaedics, vascular, dental, consumer healthcare, pharmaceutical, wound care, and medical devices.
26 September, 2018